Neurocrine Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Neurocrine Biosciences, Inc.: Is Infosys Ltd. worth buying?
Item: Neurocrine Biosciences, Inc.
Rating: 2.168291625
Author: Trendlyne DVM scores

Momentum Trap

about

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

152.16 0.58 (0.38%)

Near 52W High of $157.67

501.0K

XNAS Volume

XNAS 28 Nov, 2025 4:30 PM (EST)

Low Financial Strength

33.3 / 100

Mid Valuation

36.7 / 100

Technically Bullish

70.1 / 100

Momentum Trap These stocks are with bad quality but mid-range Valuation. However, their good technical scoring may generate some interest amongst the audience. View Similar Embed DVM

175

1Yr Price target upside is 15%

27 analysts

Neurocrine Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neurocrine Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Near 52W High of $157.67

SWOT Analysis

Neurocrine Biosciences Inc Live Price Chart